Amrubicin monotherapy may be an effective second-line treatment for patients with large-cell neuroendocrine carcinoma or high-grade non-small-cell neuroendocrine carcinoma

There is no standard chemotherapy for pulmonary large-cell neuroendocrine carcinoma (LCNEC) and this type of cancer is difficult to diagnose using biopsy specimens. At the Shizuoka Cancer Center, when small biopsy specimens are used, they are diagnosed as high-grade non-small-cell neuroendocrine car...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Molecular and clinical oncology 2017-05, Vol.6 (5), p.718-722
Hauptverfasser:	Kasahara, Norimitsu, Wakuda, Kazushige, Omori, Shota, Nakashima, Kazuhisa, Ono, Akira, Taira, Tetsuhiko, Kenmotsu, Hirotsugu, Naito, Tateaki, Murakami, Haruyasu, Mori, Keita, Watanabe, Reiko, Endo, Masahiro, Nakajima, Takashi, Yamada, Masanobu, Takahashi, Toshiaki
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Anthracyclines Biopsy Cancer therapies Care and treatment Chemotherapy Dosage and administration Hematology Labeling Morphology Neuroendocrine tumors Neutropenia Oncology Patients Treatment outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!